Siegfried Expands Manufacturing with New Facility in Germany

Siegfried AG has inaugurated a new large-scale production facility for manufacturing pharmaceutical ingredients in Minden, Germany. With this addition, Siegfried strengthens its position as a leading global Contract Development and Manufacturing Organization (CDMO). The facility adds 100 m³ of reactor capacity, enhancing the company's ability to deliver complex and scalable API solutions for its clients.

Marcel Imwinkelried, CEO of Siegfried, emphasized that the new facility marks a crucial milestone in their global growth strategy, reinforcing their capability to handle commercial scale API manufacturing. The plant boasts advanced technology, including gravity-flow processing and RFID-enabled recipe management, ensuring efficient and safe production processes.

This expansion aligns with Siegfried's strategic priorities of operational excellence and long-term partnerships with pharmaceutical customers, further supporting increasing market demands.